Vimarsana
Biggest News Aggregation in the World

Page 3 - Presented August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presented August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presented August Today - Breaking & Trending Today

NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS) - Vimarsana News

NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS)

Published: January 3, 2023

/PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announced an agreement with the...

Source: prnewswire.com
Related Topics:
Alexandraa WolfarthBennyj ChenSara FerrandoYujing ZouRadiation Research SocietyBenny Chen At Duke UniversityNational Institute Of AllergyUs National Institutes Of HealthDrug AdministrationPrnewswire Neoimmunetech IncNeoimmunetech IncInternational MeetingChernobyl Nuclear Power PlantRadiation Injury Treatment NetworkNational InstituteInfectious DiseasesAcute Radiation SyndromeChief Executive OfficerBenny ChenDuke UniversityInjury Treatment NetworkAnnual MeetingRadiation SyndromeYiqun JiaoByung Ha Lee
Vintage Drug Atop Loop Diuretics Boosts ADHF Decongestion: ADVOR - Vimarsana News

Vintage Drug Atop Loop Diuretics Boosts ADHF Decongestion: ADVOR

Published: August 27, 2022

Adding the IV drug to loop diuretics in the ADVOR trial improved decongestion success in volume-overloaded patients with acute decompensated heart failure, researchers reported.

Source: medscape.com
Related Topics:
Region FlamandeUniversity Of Texas Southwestern Medical CenterUnited StatesNorth CarolinaDuke UniversityComunidad Autonoma De CatalunaWilfried MullensMarkh DraznerBristol Myers SquibbG Michael FelkerEuropean Society Of Cardiology CongressDuke University School Of MedicineAbbott FundBelgian Health Care Knowledge CenterBoehringer IngelheimBoston ScientificEuropean Society Of CardiologyHospital Oost LimburgEuropean SocietyDecompensated Heart FailureVolume OverloadNew England JournalTexas Southwestern Medical CenterDuke University SchoolBelgian Health Care Knowledge
Experts Debate Merits of Dual Therapy for Lupus Nephritis - Vimarsana News

Experts Debate Merits of Dual Therapy for Lupus Nephritis

Published: August 20, 2021

Brad Rovin, MD, and Richard Furie, MD, discussed the merits of dual therapy with voclosporin or belimumab in lupus nephritis but said response rates leave a lot of room for improvement.

Source: medscape.com
Related Topics:
New YorkUnited StatesBrad RovinRicharda FurieGraciela AlarconPan American LeagueDrug AdministrationUniversity Of Alabama At BirminghamOhio State University Wexner Medical CenterBarbara Zucker SchoolAmerican LeaguePresented AugustSystemic Lupus ErythematosusLupus NephritisEnd Stage Renal Disease EsrdEnd Stage Renal DiseaseKidney Ureter BladderUb Kidney Ureter Bladder Immunosuppressive TherapyImmunosuppressive AgentsImmunosuppressive DrugsRug Immunosuppressive Polyarteritis NodosaEriarteritis Nodosaபுதியது யார்க்